糖尿病網膜症の世界市場レポート 2024

糖尿病網膜症の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には7.4%の年間複合成長率（CAGR）で114億米ドルに成長すると予想されます。予測期間で予想される成長は、個別化医療アプローチの採用、遠隔医療サービスの拡大、新たな治療介入の開発、ポイントオブケア検査の採用増加、および遠隔患者モニタリングの実施に起因すると考えられます。予測期間における注目すべき動向としては、糖尿病網膜症治療における精密医療の応用、早期発見と予防への重点の集中、遠隔眼科サービスの成長、遺伝子治療における調査の増加、網膜画像技術の継続的な進歩などが挙げられます。

糖尿病網膜症市場の予想される成長は、糖尿病の有病率の増加によって促進されると予想されます。糖尿病は、長期間にわたる血糖値の上昇を特徴とし、過体重、肥満、遺伝、運動不足などの要因の影響を受けることがよくあります。糖尿病患者は、光を検出して脳に信号を伝達する目の部分に影響を与える網膜損傷のリスクに直面しています。たとえば、2021年 11月の時点で、国際糖尿病連盟は世界の糖尿病有病率が10.5%であり、44.7%以上の人が未診断のままであると報告しました。さらに、糖尿病人口は2030年の6億4,300万人（11.3％）から2045年には7億8,300万人（12.2％）に増加すると予測されています。したがって、糖尿病有病率の上昇は糖尿病網膜症市場の成長の重要な原動力となっています。

高齢者の割合の増加も、糖尿病網膜症市場の成長に寄与すると予想されます。加齢と老化プロセスを特徴とする高齢者は、糖尿病などの慢性疾患にかかりやすくなります。この人口動態の変化によりリスクが高まり、糖尿病網膜症に対して脆弱な人口が拡大します。たとえば、米国国勢調査局のデータによると、2023年 6月時点で、進行中の高齢化傾向を反映して、国の平均年齢が2022年には38.9歳に上昇することが示されています。したがって、高齢化人口の増加が糖尿病網膜症市場拡大の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の糖尿病網膜症市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 増殖性糖尿病網膜症
• 非増殖性糖尿病網膜症
• 世界の糖尿病網膜症市場、治療別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 抗VEGF薬
• ステロイド眼内注射
• レーザー光凝固術
• 網膜硝子体手術
• 世界の糖尿病網膜症市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院
• 外来手術センター
• その他のエンドユーザー

第7章 地域および国の分析

• 世界の糖尿病網膜症市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界の糖尿病網膜症市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 糖尿病網膜症市場の競合情勢
• 糖尿病網膜症市場の企業プロファイル
  • Pfizer Inc.
  • F-Hoffmann-La Roche Ltd.
  • AbbVie Inc.
  • Bayer AG
  • Novartis AG

第31章 その他の大手および革新的な企業

• Ellex Medical Lasers Ltd.
• Abbott Laboratories Inc.
• Regeneron Pharmaceuticals Inc.
• Bausch Health Companies Inc.
• Icon Bioscience Inc.
• Allergan plc.
• Genentech Inc.
• Aurobindo Pharma
• Santen Pharmaceutical Co. Ltd.
• Carl Zeiss Meditec AG
• Valeant Pharmaceuticals International Inc.
• Lumenis Ltd.
• Optos Plc.
• Quantel Medical SAS
• NIDEK Co. Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Diabetic retinopathy is an ocular condition that has the potential to result in blindness and vision impairment among individuals with diabetes, impacting the blood vessels within the retina and the light-sensitive tissue layer situated at the back of the eye. This condition commonly gives rise to diabetic macular edema (DME) and neovascular glaucoma.

The primary types of diabetic retinopathy include proliferative diabetic retinopathy and non-proliferative diabetic retinopathy. Proliferative diabetic retinopathy represents the advanced stage characterized by the emergence of abnormal new blood vessels on the surface of the retina. Various treatment modalities, such as anti-VEGF drugs, intraocular steroid injections, laser photocoagulation, and vitreoretinal surgery, are employed in settings such as hospitals, ambulatory surgical centers, and other healthcare facilities.

The diabetic retinopathy market research report is one of a series of new reports from The Business Research Company that provides diabetic retinopathy market statistics, including diabetic retinopathy industry global market size, regional shares, competitors with a diabetic retinopathy market share, detailed diabetic retinopathy market segments, market trends and opportunities, and any further data you may need to thrive in the diabetic retinopathy industry. This diabetic retinopathy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The diabetic retinopathy market size has grown strongly in recent years. It will grow from $7.89 billion in 2023 to $8.56 billion in 2024 at a compound annual growth rate (CAGR) of 8.5%. The growth observed in the historical period can be attributed to factors such as an aging population, a rise in the prevalence of diabetes, increased awareness regarding diabetic retinopathy, enhancements in healthcare infrastructure, and an increase in healthcare expenditure.

The diabetic retinopathy market size is expected to see strong growth in the next few years. It will grow to $11.4 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The anticipated growth in the forecast period can be attributed to the adoption of personalized medicine approaches, the expansion of telemedicine services, the development of novel therapeutic interventions, the increased adoption of point-of-care testing, and the implementation of remote patient monitoring. Notable trends in the forecast period include the application of precision medicine in diabetic retinopathy treatment, a heightened focus on early detection and prevention, the growth of teleophthalmology services, increased research in gene therapy, and ongoing advancements in retinal imaging technology.

The anticipated growth of the diabetic retinopathy market is expected to be propelled by the increasing prevalence of diabetes. Diabetes is characterized by prolonged elevated blood glucose levels, often influenced by factors such as overweight, obesity, genetics, and physical inactivity. Individuals with diabetes face the risk of retinal damage, impacting the part of the eye responsible for detecting light and transmitting signals to the brain. For example, as of November 2021, the International Diabetes Federation reported a global diabetes prevalence of 10.5%, with over 44.7% of individuals remaining undiagnosed. Furthermore, it is projected that the diabetic population will increase from 643 million (11.3%) in 2030 to 783 million (12.2%) in 2045. Hence, the rising prevalence of diabetes is a significant driver of the diabetic retinopathy market's growth.

The increasing proportion of aging individuals is also expected to contribute to the growth of the diabetic retinopathy market. Aging individuals, characterized by advancing age and the aging process, are more susceptible to chronic conditions such as diabetes. This demographic shift elevates the risk and expands the population vulnerable to diabetic retinopathy. For instance, data from the United States Census Bureau, as of June 2023, indicated a rise in the country's median age to 38.9 years in 2022, reflecting an ongoing aging trend. Consequently, the growing proportion of aging individuals serves as a driving force for the diabetic retinopathy market's expansion.

Technological advancements represent a prominent trend gaining traction in the diabetic retinopathy market. Major companies within this market are embracing innovative technologies to maintain their competitive standing. For instance, in July 2022, Baxter International Inc., a US-based healthcare company, introduced the Welch Allyn RetinaVue 100 Imager PRO in South Korea. These cutting-edge technologies aim to facilitate the detection of diabetic retinopathy in primary care settings, streamlining the process for annual diabetic retinal exams (DREs) during routine primary care visits and enhancing patient compliance.

Companies operating in the diabetic retinopathy market are strategically entering partnerships to enhance their market profitability. Collaborations in the context of diabetic retinopathy involve coordinated efforts among diverse stakeholders, including healthcare providers, researchers, pharmaceutical companies, and advocacy groups, to address challenges associated with diabetic retinopathy. For example, in October 2023, AEYE Health, a US-based provider of AI-based diagnostics for retinal imaging, joined forces with Topcon Screen, a Japan-based diabetic screening platform. Their collaboration aims to offer point-of-care screening for diabetic retinopathy using artificial intelligence, ensuring swift and precise results. This approach enables primary care clinicians to conduct diabetic retinopathy screenings directly in their clinics, reducing non-compliance risks and addressing care gaps associated with diabetic retinopathy screening through immediate and accurate assessments at the point of care.

In January 2022, Meteda, a US-based healthcare technology company, completed the acquisition of Retmarker SA for an undisclosed amount. Through this strategic move, Meteda seeks to broaden its access to periodic screening for diabetic retinopathy, utilize AI to address various diabetes-related issues, and strengthen its position in the EMEA region. Retmarker SA, based in Portugal, is an AI technology company specializing in ophthalmology, particularly focusing on retinal conditions such as diabetic retinopathy.

Major companies operating in the diabetic retinopathy market report are Pfizer Inc., F-Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Ellex Medical Lasers Ltd., Abbott Laboratories Inc., Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Icon Bioscience Inc., Allergan plc., Genentech Inc., Aurobindo Pharma, Santen Pharmaceutical Co. Ltd., Carl Zeiss Meditec AG, Valeant Pharmaceuticals International Inc., Lumenis Ltd., Optos Plc., Quantel Medical SAS, NIDEK Co. Ltd., IRIDEX Corporation, Alimera Science Inc., Kowa Company Ltd., Ocular Therapeutix Inc., Aerpio Pharmaceuticals Inc., Kodiak Sciences Inc., Sirnaomics Inc., Oxurion NV, Graybug Vision Inc., Ampio Pharmaceuticals Inc.

North America was the largest region in the diabetic retinopathy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic retinopathy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the diabetic retinopathy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diabetic retinopathy market includes revenues earned by entities by providing ophthalmologic examination, eye management and retinal imaging and monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diabetic Retinopathy Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diabetic retinopathy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for diabetic retinopathy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The diabetic retinopathy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Proliferative Diabetic Retinopathy; Non-Proliferative Diabetic Retinopathy
• 2) By Treatment: Anti-VEGF Drugs; Intraocular Steroid Injection; Laser Photocoagulation; Vitreoretinal Surgery
• 3) By End-User: Hospitals; Ambulatory Surgical Centers; Other End Users
• Companies Mentioned: Pfizer Inc.; F-Hoffmann-La Roche Ltd.; AbbVie Inc.; Bayer AG; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Diabetic Retinopathy Market Characteristics

3. Diabetic Retinopathy Market Trends And Strategies

4. Diabetic Retinopathy Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Diabetic Retinopathy Market Size and Growth

• 5.1. Global Diabetic Retinopathy Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Diabetic Retinopathy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Diabetic Retinopathy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Diabetic Retinopathy Market Segmentation

• 6.1. Global Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Proliferative Diabetic Retinopathy
• Non-Proliferative Diabetic Retinopathy
• 6.2. Global Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Anti-VEGF Drugs
• Intraocular Steroid Injection
• Laser Photocoagulation
• Vitreoretinal Surgery
• 6.3. Global Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Other End Users

7. Diabetic Retinopathy Market Regional And Country Analysis

• 7.1. Global Diabetic Retinopathy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Diabetic Retinopathy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Diabetic Retinopathy Market

• 8.1. Asia-Pacific Diabetic Retinopathy Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Diabetic Retinopathy Market

• 9.1. China Diabetic Retinopathy Market Overview
• 9.2. China Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Diabetic Retinopathy Market

• 10.1. India Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Diabetic Retinopathy Market

• 11.1. Japan Diabetic Retinopathy Market Overview
• 11.2. Japan Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Diabetic Retinopathy Market

• 12.1. Australia Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Diabetic Retinopathy Market

• 13.1. Indonesia Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Diabetic Retinopathy Market

• 14.1. South Korea Diabetic Retinopathy Market Overview
• 14.2. South Korea Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Diabetic Retinopathy Market

• 15.1. Western Europe Diabetic Retinopathy Market Overview
• 15.2. Western Europe Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Diabetic Retinopathy Market

• 16.1. UK Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Diabetic Retinopathy Market

• 17.1. Germany Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Diabetic Retinopathy Market

• 18.1. France Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Diabetic Retinopathy Market

• 19.1. Italy Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Diabetic Retinopathy Market

• 20.1. Spain Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Diabetic Retinopathy Market

• 21.1. Eastern Europe Diabetic Retinopathy Market Overview
• 21.2. Eastern Europe Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Diabetic Retinopathy Market

• 22.1. Russia Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Diabetic Retinopathy Market

• 23.1. North America Diabetic Retinopathy Market Overview
• 23.2. North America Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Diabetic Retinopathy Market

• 24.1. USA Diabetic Retinopathy Market Overview
• 24.2. USA Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Diabetic Retinopathy Market

• 25.1. Canada Diabetic Retinopathy Market Overview
• 25.2. Canada Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Diabetic Retinopathy Market

• 26.1. South America Diabetic Retinopathy Market Overview
• 26.2. South America Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Diabetic Retinopathy Market

• 27.1. Brazil Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Diabetic Retinopathy Market

• 28.1. Middle East Diabetic Retinopathy Market Overview
• 28.2. Middle East Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Diabetic Retinopathy Market

• 29.1. Africa Diabetic Retinopathy Market Overview
• 29.2. Africa Diabetic Retinopathy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Diabetic Retinopathy Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Diabetic Retinopathy Market Competitive Landscape And Company Profiles

• 30.1. Diabetic Retinopathy Market Competitive Landscape
• 30.2. Diabetic Retinopathy Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. F-Hoffmann-La Roche Ltd.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. AbbVie Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Bayer AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Novartis AG
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Diabetic Retinopathy Market Other Major And Innovative Companies

• 31.1. Ellex Medical Lasers Ltd.
• 31.2. Abbott Laboratories Inc.
• 31.3. Regeneron Pharmaceuticals Inc.
• 31.4. Bausch Health Companies Inc.
• 31.5. Icon Bioscience Inc.
• 31.6. Allergan plc.
• 31.7. Genentech Inc.
• 31.8. Aurobindo Pharma
• 31.9. Santen Pharmaceutical Co. Ltd.
• 31.10. Carl Zeiss Meditec AG
• 31.11. Valeant Pharmaceuticals International Inc.
• 31.12. Lumenis Ltd.
• 31.13. Optos Plc.
• 31.14. Quantel Medical SAS
• 31.15. NIDEK Co. Ltd.

32. Global Diabetic Retinopathy Market Competitive Benchmarking

33. Global Diabetic Retinopathy Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Diabetic Retinopathy Market

35. Diabetic Retinopathy Market Future Outlook and Potential Analysis

• 35.1 Diabetic Retinopathy Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Diabetic Retinopathy Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Diabetic Retinopathy Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer